A clinical trial is a research study involving human volunteers, and is designed to answer specific health questions. Carefully conducted clinical trials are the safest and fastest way to find effective treatments, and new ways to improve health.
You can search for all studies that are currently enrolling participants at the University of Rochester by typing in keywords in the search box below. If you don’t find a study that interests you right now, consider signing up for our Volunteer Registry, which will notify you of future studies.
Search Clinical Trials and Research Studies
Sorry, we could not find any results matching heart.
View All Clinical Studies
Management of the PDA Trial
Lead Researcher: Carl D'angio
Patent ductus arteriosus (PDA) is an extra blood vessel found in babies before birth
and just after birth. In most babies who have an otherwise normal heart, the PDA
will shrink and close on its own in the first few days of life. If it stays open longer,
it may cause extra blood to flow to the lungs. This study estimates the risks and
benefits of active treatment versus expectant management of premature babies with
patent ductus arteriosus.
View Study Details
Study of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus in Adults
Lead Researcher: Ann Falsey
RSV is a virus that causes respiratory tract infections, which affect the lungs. RSV
symptoms include runny nose, stuffy nose, wheezing, cough, sore throat, fever, and
shortness of breath. RSV is the most common cause of severe lung infections and hospitalizations
in young children and can cause lung infections in older adults. Both older adults
with other health conditions, such as heart or lung disease, and adults who have received
an organ transplant are at higher risk of serious illness from RSV infection. Vaccines
help protect people from disease by causing the body to produce antibodies, which
are proteins that fight off infection. There is currently no vaccine for RSV. This
clinical trial is studying a new vaccine called mRNA-1345 to see if it can prevent
RSV. You are eligible for this trial if you are 18–59 years old and have either diabetes,
coronary artery disease, congestive heart failure, or lung disease. You are also
eligible if you are >18 years old and have received an organ transplant more than
180 days ago.
View Study Details
Studies for Healthy Volunteers Cancer Research Studies